Abstract
INTRODUCTION: Individuals living in rural communities are at heightened risk for Alzheimer's disease and related dementias (ADRD), which parallels other persistent place-based health disparities. Identifying multiple potentially modifiable risk factors specific to rural areas that contribute to ADRD is an essential first step in understanding the complex interplay between various barriers and facilitators. METHODS: An interdisciplinary, international group of ADRD researchers convened to address the overarching question of: “What can be done to begin minimizing the rural health disparities that contribute uniquely to ADRD?” In this state of the science appraisal, we explore what is known about the biological, behavioral, sociocultural, and environmental influences on ADRD disparities in rural settings. RESULTS: A range of individual, interpersonal, and community factors were identified, including strengths of rural residents in facilitating healthy aging lifestyle interventions. DISCUSSION: A location dynamics model and ADRD-focused future directions are offered for guiding rural practitioners, researchers, and policymakers in mitigating rural disparities. HIGHLIGHTS: Rural residents face heightened Alzheimer's disease and related dementia (ADRD) risks and burdens due to health disparities. Defining the unique rural barriers and facilitators to cognitive health yields insight. The strengths and resilience of rural residents can mitigate ADRD-related challenges. A novel “location dynamics” model guides assessment of rural-specific ADRD issues.
| Original language | English |
|---|---|
| Pages (from-to) | 4204-4225 |
| Number of pages | 22 |
| Journal | Alzheimer's and Dementia |
| Volume | 19 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2023 |
Bibliographical note
Publisher Copyright:© 2023 the Alzheimer's Association.
Funding
Lisa Ann Kirk Wiese received funding from National Institute of Health/National Institute on Aging (K01AG064047) and Florida Department of Health, Ed and Ethel Moore Research Foundation. Christine L. Williams was supported by NIH/NIA (R01 56AG064094). Allison Gibson received funding from National Institute of Health/National Institute on Aging (P30AG072946) and University of Kentucky, Sanders‐Brown Center on Aging. Amy R. Nelson received funding from NIH/NINDS (U19NS120384). Frederick P. Whiddon was supported by National Institute on Health/National Institutes of Aging (R00AG058780) and AlzOut. Aditi Gupta was supported by funding K23AG055555 and R61/33AG068483. Owen Carmichael was supported by NIH (grants AG078533, AG078558, AG07425801, AG077497, AG077000, AG067765, AG041200, AG062309, AG062200, AG069476). Allison Lindauer was supported by funding from NIH/NIA (R01AG067596; P30AG066518; P30AG042978). Rachel Peterson received funding from National Institute of Health/National Institute on Aging (4R00AG073457‐02). Elizabeth K. Rhodus was funded by National Institute of Health/National Institute on Aging (P30AG072946) and NIH/NIA (K23AG075262). Christina G. Wong was funded by Nevada Exploratory Alzheimer's Disease Research Center (under Award Number P20 AG068053) and the National Institute of General Medical Science (NIGMS) (under Award Number P20 GM109025). Megan Zuelsdorff was supported by funding (AARF‐18‐562958 and R03AG063303). Justin Miller received funding from Nevada Exploratory Alzheimer's Disease Research Center (under Award Number P20 AG068053) and the National Institute of General Medical Sciences (NIGMS) (under Award Number P20 GM109025). Sanne Franzen has received consulting fees from Biogen (paid to her organization). She has also received honoraria for lectures and speaking at panels. SF receives support through the ABOARD project, a public–private partnership funded by ZonMW (#73305095007) and Health‐Holland, Topsector Life Sciences & Health (PPP‐allowance; #LSHM20106). Caitlin N. Pope was supported by a research career development award (K12DA035150: Building Interdisciplinary Research Careers in Women's Health Program‐BIRCWH) from the National Institutes of Health Office of Research on Women's Health and the National Institute on Drug Abuse. Patricia C. Heyn was supported by National Institute of Health (5TR13AG072884‐02, NIH 1R13AT011146‐01, HHS, ACL, 90FPSG0063). Beth Prusaczyk was supported by NIH/NIA (K01AG071749). Ambar Kulshreshtha was supported by funding from NIH/NIA (K23 AG066931‐01A1). Veronica Yank received grants from National Institute of Health/National Institute on Aging (R01AG057855 and NIA R01AG072057). Lilah was supported by funding from NIH/NIA K01AG063895, NIH/NIA R21AG075291, and an Alzheimer's Association Research Grant (AARG‐21‐850963). Jon Corkey Amissa Corporation was supported by funding from the NIH /National Institute on Aging (1R43AG072981‐01A1) and National Science Foundation (#2127407). Ganesh M. Babulal was supported by the National Institute of Health/National Institute on Aging (grant numbers: R01 AG074302, R01 AG068183, R01 AG067428, R01 AG056466) and by the BrightFocus Foundation (A2021142S). Sheryl Magzamen was supported by funding from the NASA Health and Air Quality Applied Sciences Team. This manuscript was facilitated by the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART), through the Diversity and Disparities Professional Interest Area (PIA). The views and opinions expressed by authors in this publication represent those of the authors and do not necessarily reflect those of the PIA membership, ISTAART, or the Alzheimer's Association. Lisa Ann Kirk Wiese received funding from National Institute of Health/National Institute on Aging (K01AG064047) and Florida Department of Health, Ed and Ethel Moore Research Foundation. Christine L. Williams was supported by NIH/NIA (R01 56AG064094). Allison Gibson received funding from National Institute of Health/National Institute on Aging (P30AG072946) and University of Kentucky, Sanders-Brown Center on Aging. Amy R. Nelson received funding from NIH/NINDS (U19NS120384), National Institute on Health/National Institutes of Aging (R00AG058780) and AlzOut. Aditi Gupta was supported by funding K23AG055555 and R61/33AG068483. Owen Carmichael was supported by NIH (grants AG078533, AG078558, AG07425801, AG077497, AG077000, AG067765, AG041200, AG062309, AG062200, AG069476). Allison Lindauer was supported by funding from NIH/NIA (R01AG067596; P30AG066518; P30AG042978). Rachel Peterson received funding from National Institute of Health/National Institute on Aging (4R00AG073457-02). Elizabeth K. Rhodus was funded by National Institute of Health/National Institute on Aging (P30AG072946) and NIH/NIA (K23AG075262). Christina G. Wong was funded by Nevada Exploratory Alzheimer's Disease Research Center (under Award Number P20 AG068053) and the National Institute of General Medical Science (NIGMS) (under Award Number P20 GM109025). Megan Zuelsdorff was supported by funding (AARF-18-562958 and R03AG063303). Justin Miller received funding from Nevada Exploratory Alzheimer's Disease Research Center (under Award Number P20 AG068053) and the National Institute of General Medical Sciences (NIGMS) (under Award Number P20 GM109025). Sanne Franzen has received consulting fees from Biogen (paid to her organization). She has also received honoraria for lectures and speaking at panels. SF receives support through the ABOARD project, a public–private partnership funded by ZonMW (#73305095007) and Health-Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). Caitlin N. Pope was supported by a research career development award (K12DA035150: Building Interdisciplinary Research Careers in Women's Health Program-BIRCWH) from the National Institutes of Health Office of Research on Women's Health and the National Institute on Drug Abuse. Patricia C. Heyn was supported by National Institute of Health (5TR13AG072884-02, NIH 1R13AT011146-01, HHS, ACL, 90FPSG0063). Beth Prusaczyk was supported by NIH/NIA (K01AG071749). Ambar Kulshreshtha was supported by funding from NIH/NIA (K23 AG066931-01A1). Veronica Yank received grants from National Institute of Health/National Institute on Aging (R01AG057855 and NIA R01AG072057). Lilah was supported by funding from NIH/NIA K01AG063895, NIH/NIA R21AG075291, and an Alzheimer's Association Research Grant (AARG-21-850963). Jon Corkey Amissa Corporation was supported by funding from the NIH /National Institute on Aging (1R43AG072981-01A1) and National Science Foundation (#2127407). Ganesh M. Babulal was supported by the National Institute of Health/National Institute on Aging (grant numbers: R01 AG074302, R01 AG068183, R01 AG067428, R01 AG056466) and by the BrightFocus Foundation (A2021142S). Sheryl Magzamen was supported by funding from the NASA Health and Air Quality Applied Sciences Team. [Correction added on May 25, 2023, after first online publication: Acknowledgments have been corrected for Amy. R. Nelson].
| Funders | Funder number |
|---|---|
| Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment | |
| Building Interdisciplinary Research Careers in Women's Health Program-BIRCWH | |
| Ethel Moore Research Foundation | |
| Mental Health Services North-Holland North | |
| ISTAART | |
| NASA Health and Air Quality Applied Sciences Team | |
| National Institutes of Health Office of Research on Women's Health | |
| Nevada Exploratory Alzheimer's Disease Research Center | P20 AG068053 |
| Sanders-Brown Center on Aging | |
| Topsector Life Sciences & Health | K12DA035150, 20106 |
| Sanders-Brown Center on Aging, University of Kentucky | |
| National Science Foundation Arctic Social Science Program | 2127407, R01 AG074302, R01 AG068183, R01 AG067428, R01 AG056466 |
| National Institutes of Health (NIH) | |
| U.S. Department of Health and Human Services | |
| Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug Abuse | 5TR13AG072884‐02, 1R13AT011146‐01 |
| National Institute on Aging | AG069476, R01 56AG064094, AG041200, K01AG064047, AG062309, AG067765, AG07425801, P30AG042978, P30AG066518, 4R00AG073457‐02, AG062200, R61/33AG068483, AG077000, AG077497, AG078533, K23AG055555, K23AG075262, R00AG058780, R01AG067596, AG078558, P30AG072946 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | P20 GM109025, R03AG063303, AARF‐18‐562958 |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | U19NS120384 |
| Alzheimer's Association | |
| Administration for Community Living | AARG‐21‐850963, R21AG075291, 1R43AG072981‐01A1, K01AG063895, 90FPSG0063, K01AG071749, R01AG057855, R01AG072057, K23 AG066931‐01A1 |
| BrightFocus Foundation | A2021142S |
| Florida Department of Health | |
| University of Kentucky | |
| ZonMw Memorabel | 73305095007 |
Keywords
- community engagement
- community-based action
- facilitators and barriers to ADRD diagnosis and treatment
- global disparities
- health disparities
- location dynamics
- modifiable ADRD risk factors
- rural
- rural culture
- under-represented
- underserved
ASJC Scopus subject areas
- Epidemiology
- Health Policy
- Developmental Neuroscience
- Clinical Neurology
- Geriatrics and Gerontology
- Cellular and Molecular Neuroscience
- Psychiatry and Mental health